Ticagrelor plasma concentration, metabolite ratio, and LDH level as independent risk factors for ticagrelor-induced dyspnea in ACS patients

• by Yazi Zhao, Mengqi Gong, Yong Su, Jiaxin Zhao, Fangde Hong, Zheyuan Lu, Mengqing Ma, Meijie Jiang, Youfeng Liang

• June 23, 2026

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

• by Kathryn Wighton

• May 14, 2026

• 6 min

Pregnancy-Linked SCAD More Severe

Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.

• by Kerri Miller

• March 30, 2026

• 2 min

Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome

• by Nour Eldeen Mahmoud Shabaan Ibrahim, Mohamed Tarek Mounir Zaki, Khaled Ahmed Fouad Abdel Magid, Khaled Ahmed Fouad, Mina Magued Abdalla Iskandar

• March 27, 2026